Hubei Goto Biopharm Co.,Ltd. (300966.SZ) SHZ

22.45

+0.62(+2.84%)

Updated at October 20 03:04PM

Currency In CNY

Valuation

Market Cap1.86B
Enterprise Value2.83B
P/E Ratio-76.97
PEG Ratio5
Price/Sales Ratio4.28
Price/Book Ratio2.85
Enterprise/Revenue6.02
Enterprise/EBITDA-1,320.92

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.06
Operating Margin-0.08

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.04

Income Statement

Revenue536.6M
Revenue/Share5.25
Gross Profit105.56M
EBITDA21.23M
Net Income-27.59M
Diluted EPS-0.24

Balance Sheet

Total Cash133.83M
Total Cash/Share1.16
Total Debt1.19B
Total Debt/Equity1.31
Current Ratio1.04
Book Value Per Share8.65

Price History

52-Week Change21.09
52-Week High29.77
52-Week Low13.04
Moving Average 50 Days22.42
Moving Average 200 Days18.67

Statistics

Average Volume5.91M
Shares Outstanding115.28M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.8
Last Split FactorN/A
Last Split DateN/A